These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17496009)

  • 1. Subtraction SPECT for parathyroid scintigraphy based on maximization of mutual information.
    Hara N; Takayama T; Onoguchi M; Obane N; Miyati T; Yoshioka T; Sakaguchi K; Honda M
    J Nucl Med Technol; 2007 Jun; 35(2):84-90. PubMed ID: 17496009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings.
    Nichols KJ; Tomas MB; Tronco GG; Rini JN; Kunjummen BD; Heller KS; Sznyter LA; Palestro CJ
    Radiology; 2008 Jul; 248(1):221-32. PubMed ID: 18483228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive
    Dugonjić S; Šišić M; Radulović M; Ajdinović B
    Hell J Nucl Med; 2017; 20(1):46-50. PubMed ID: 28315908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
    Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
    J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
    Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
    AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
    Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
    Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
    Neumann DR; Obuchowski NA; Difilippo FP
    J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD; Dupont JO; Bybel B; Riese KT
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
    Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
    J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-isotope 99mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan.
    Hassler S; Ben-Sellem D; Hubele F; Constantinesco A; Goetz C
    Clin Nucl Med; 2014 Jan; 39(1):32-6. PubMed ID: 24152647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal interpretative strategy for preoperative parathyroid scintigraphy.
    Bahador FM; Latifi HR; Grossman SJ; Oza UD; Xu H; Griffeth LK
    Clin Nucl Med; 2015 Feb; 40(2):116-22. PubMed ID: 25525929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [99m-Tc-MIBI SPECT parathyroid gland scintigraphy for the preoperative localization of small parathyroid gland adenomas].
    Moka D; Voth E; Larena-Avellaneda A; Schicha H
    Nuklearmedizin; 1997 Oct; 36(7):240-4. PubMed ID: 9441283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
    Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
    J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism.
    Spanu A; Falchi A; Manca A; Marongiu P; Cossu A; Pisu N; Chessa F; Nuvoli S; Madeddu G
    J Nucl Med; 2004 Jan; 45(1):40-8. PubMed ID: 14734671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy.
    Thomas DL; Bartel T; Menda Y; Howe J; Graham MM; Juweid ME
    Clin Nucl Med; 2009 Oct; 34(10):651-5. PubMed ID: 19893394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
    Rink T; Schroth HJ; Holle LH; Garth H
    J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography.
    Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
    Nucl Med Commun; 2003 Jul; 24(7):755-62. PubMed ID: 12813193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid scintigraphy with 99mTc sestamibi.
    Bernà L; Sitges-Serra A
    Nucl Med Commun; 2003 May; 24(5):485-8. PubMed ID: 12717063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.